Little is known about the effects of ionizing radiation on the earliest stages of embryonic development although it is well recognized that ionizing radiation is a natural part of our environment and further exposure may occur due to medical applications. The current study addresses this issue using D3 mouse embryonic stem cells as a model system. Cells were irradiated with either X-rays or carbon ions representing sparsely and densely ionizing radiation and their effect on the differentiation of D3 cells into spontaneously contracting cardiomyocytes through embryoid body (EB) formation was measured. This study is the first to demonstrate that ionizing radiation impairs the formation of beating cardiomyocytes with carbon ions being more detrimental than X-rays. However, after prolonged culture time, the number of beating EBs derived from carbon ion irradiated cells almost reached control levels indicating that the surviving cells are still capable of developing along the cardiac lineage although with considerable delay. Reduced EB size, failure to downregulate pluripotency markers, and impaired expression of cardiac markers were identified as the cause of compromised cardiomyocyte formation. Dysregulation of cardiac differentiation was accompanied by alterations in the expression of endodermal and ectodermal markers that were more severe after carbon ion irradiation than after exposure to X-rays. In conclusion, our data show that carbon ion irradiation profoundly affects differentiation and thus may pose a higher risk to the early embryo than X-rays.
Get full access to this article
View all access options for this article.
References
1.
ScholzM. (2003). Effects of ion radiation on cells and tissues. Adv Polym Sci, 162:95–156.
2.
HendryJH, SimonSL, WojcikA, SohrabiM, BurkartW, CardisE, LaurierD, TirmarcheM and HayataI. (2009). Human exposure to high natural background radiation: what can it teach us about radiation risks?. J Radiol Prot, 29:A29–A42.
3.
DuranteM and LoefflerJS. (2010). Charged particles in radiation oncology. Nat Rev Clin Oncol, 7:37–43.
4.
McColloughCH, SchuelerBA, AtwellTD, BraunNN, RegnerDM, BrownDL and LeRoyAJ. (2007). Radiation exposure and pregnancy: when should we be concerned?. Radiographics, 27:909–918.
5.
RatnapalanS, BonaN and KorenG. (2003). Ionizing radiation during pregnancy. Can Fam Physician, 49:873–874.
6.
Goldberg-SteinS, LiuB, HahnPF and LeeSI. (2011). Body CT during pregnancy: utilization trends, examination indications, and fetal radiation doses. AJR Am J Roentgenol, 196:146–151.
7.
RamanathanS and RyanJ. (2015). Radiation awareness among radiology residents, technologists, fellows and staff: where do we stand?. Insights Imaging, 6:133–139.
8.
StrefferC, ShoreR, KonermannG, MeadowsA, Uma DeviP, PrestonJ, HolmLE, StatherJ, MabuchiK and WithersHR. (2003). Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiobiological Protection. Ann ICRP, 33:5–206.
9.
SchroederIS, WieseC, TruongTT, RolletschekA and WobusAM. (2009). Differentiation analysis of pluripotent mouse embryonic stem (ES) cells in vitro. In: Gene Knockout Protocols. KuehnR and WurstW, eds. Humana Press, a part of Springer Science & Business Media, New York, pp 219–250.
10.
GenschowE, SpielmannH, ScholzG, SeilerA, BrownN, PiersmaA, BradyM, ClemannN, HuuskonenH, et al. (2002). The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern Lab Anim, 30:151–176.
11.
WobusAM and LöserP. (2011). Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol, 85:79–117.
12.
AbassiYA, XiB, LiN, OuyangW, SeilerA, WatzeleM, KettenhofenR, BohlenH, EhlichA, et al. (2012). Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment. Br J Pharmacol, 165:1424–1441.
13.
DoetschmanTC, EistetterH, KatzM, SchmidtW and KemlerR. (1985). The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol, 87:27–45.
14.
Van LaakeLW, Van HoofD and MummeryCL. (2005). Cardiomyocytes derived from stem cells. Ann Med, 37:499–512.
15.
SeilerAEM and SpielmannH. (2011). The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat Protoc, 6:961–978.
16.
BuesenR, GenschowE, SlawikB, VisanA, SpielmannH, LuchA and SeilerA. (2009). Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol Sci, 108:389–400.
17.
LoefflerJS and DuranteM. (2013). Charged particle therapy—optimization, challenges and future directions. Nat Rev Clin Oncol, 10:411–424.
18.
LuftS, PignalosaD, NasonovaE, ArrizabalagaO, HelmA, DuranteM and RitterS. (2014). Fate of D3 mouse embryonic stem cells exposed to X-rays or carbon ions. Mutat Res Genet Toxicol Environ Mutagen, 760:56–63.
19.
WeyratherWK, RitterS, ScholzM and KraftG. (1999). RBE for carbon track-segment irradiation in cell lines of differing repair capacity. Int J Radiat Biol, 75:1357–1364.
20.
FrankenNAP, RodermondHM, StapJ, HavemanJ and van BreeC. (2006). Clonogenic assay of cells in vitro. Nat Protoc, 1:2315–2319.
21.
JohnsonVL, KoSCW, HolmstromTH, ErikssonJE and ChowSC. (2000). Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis. J Cell Sci, 113:2941–2953.
22.
MeijerAE, KronqvistU-SE, LewensohnR and Harms-RingdahlM. (1998). RBE for the induction of apoptosis in human peripheral lymphocytes exposed in vitro to high-LET radiation generated by accelerated nitrogen ions. Int J Radiat Biol, 73:169–177.
23.
Van VlietP, WuSM, ZaffranS and PucéatM. (2012). Early cardiac development: a view from stem cells to embryos. Cardiovasc Res, 96:352–362.
24.
ThomasJW, LaMantiaC and MagnusonT. (1998). X-ray-induced mutations in mouse embryonic stem cells. Proc Natl Acad Sci U S A, 95:1114–1119.
25.
DenissovaNG, TereshchenkoIV, CuiE, StambrookPJ, ShaoC and TischfieldJA. (2011). Ionizing radiation is a potent inducer of mitotic recombination in mouse embryonic stem cells. Mutat Res, 715:1–6.
26.
RebuzziniP, PignalosaD, MazziniG, Di LibertoR, CoppolaA, TerranovaN, MagniP, RediCA, ZuccottiM and GaragnaS. (2012). Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent differentiation potential and genome stability. J Cell Physiol, 227:1242–1249.
27.
RebuzziniP, FassinaL, MulasF, BellazziR, RediCA, Di LibertoR, MagenesG, AdjayeJ, ZuccottiM and GaragnaS. (2013). Mouse embryonic stem cells irradiated with γ-rays differentiate into cardiomyocytes but with altered contractile properties. Mutat Res, 756:37–45.
28.
SchardtD, ElsässerT and Schulz-ErtnerD. (2010). Heavy-ion tumor therapy: physical and radiobiological benefits. Rev Mod Phys, 82:383–425.
29.
BertC, Engenhart-CabillicR and DuranteM. (2012). Particle therapy for noncancer diseases. Med Phys, 39:1716–1727.
30.
MünterMW, WengenrothM, FehrenbacherG, SchardtD, NikoghosyanA, DuranteM and DebusJ. (2010). Heavy ion radiotherapy during pregnancy. Fertil Steril, 94:2329.e5–e7.
31.
HartelC, NikoghosyanA, DuranteM, SommerS, NasonovaE, FournierC, LeeR, DebusJ, Schulz-ErtnerD and RitterS. (2010). Chromosomal aberrations in peripheral blood lymphocytes of prostate cancer patients treated with IMRT and carbon ions. Radiother Oncol, 95:73–78.
32.
MessanaJM, HwangNS, CoburnJ, ElisseeffJH and ZhangZ. (2008). Size of the embryoid body influences chondrogenesis of mouse embryonic stem cells. J Tissue Eng Regen Med, 2:499–506.
33.
ManserghFC, DalyCS, HurleyAL, WrideMA, HunterSM and EvansMJ. (2009). Gene expression profiles during early differentiation of mouse embryonic stem cells. BMC Dev Biol, 9:5.
34.
ChoiYY, ChungBG, LeeDH, KhademhosseiniA, KimJ-H and LeeS-H. (2010). Controlled-size embryoid body formation in concave microwell arrays. Biomaterials, 31:4296–4303.
35.
PredaM, BurlacuA and SimionescuM. (2013). Defined-size embryoid bodies formed in the presence of serum replacement increases the efficiency of the cardiac differentiation of mouse embryonic stem cells. Tissue Cell, 45:54–60.
36.
BondueA, LapougeG, PaulissenC, SemeraroC, IacovinoM, KybaM and BlanpainC. (2008). Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell, 3:69–84.
37.
BurridgePW, KellerG, GoldJD and WuJC. (2012). Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell, 10:16–28.
38.
VerheijM and BartelinkH. (2000). Radiation-induced apoptosis. Cell Tissue Res, 301:133–142.
39.
HabermehlD, IlicicK, DehneS, RiekenS, OrschiedtL, BronsS, HabererT, WeberKJ, DebusJ and CombsSE. (2014). The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines. PLoS One, 9:e113591.
40.
HongY and StambrookPJ. (2004). Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci U S A, 101:14443–14448.
41.
TichyED. (2011). Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cells. Exp Biol Med, 236:987–996.
42.
WilsonKD, SunN, HuangM, ZhangWY, LeeAS, LiZ, WangSX and WuJC. (2010). Effects of ionizing radiation on self renewal and pluripotency of human embryonic stem cells. Cancer Res, 70:5539–5548.
43.
KarbanováJ and MokrýJ. (2002). Histological and histochemical analysis of embryoid bodies. Acta Histochem, 104:361–365.
44.
JozaN, SusinSA, DaugasE, StanfordWL, ChoSK, LiCYJ, SasakiT, EliaAJ, ChengHM, et al. (2001). Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature, 410:549–554.
45.
StefanovicS, AbboudN, DésiletsS, NuryD, CowanC and PucéatM. (2009). Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol, 186:665–673.
46.
LiuY, AsakuraM, InoueH, NakamuraT, SanoM, NiuZ, ChenM, SchwartzRJ and SchneiderMD. (2007). Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc Natl Acad Sci U S A, 104:3859–3864.
47.
SinghM, ChaudhryP and AsselinE. (2011). Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol, 210:5–14.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
